Kronos Bio Inc Financial Flexibility Index

Latest as of March 2025: -0.45x

Kronos Bio Inc financial flexibility index. Kronos Bio Inc (KRON) has a Financial Flexibility Index of -0.45x as of March 2025. Free cash flow of $-12.84 Million (operating CF $-12.84 Million minus capex $4.00K) represents 0% of total liabilities ($28.33 Million).

Financial Flexibility Index

-0.45x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-12.84 Million
Operating CF − Capex

Total Liabilities

$28.33 Million
USD

Capital Expenditures

$4.00K
USD

Financial Flexibility Index of Kronos Bio Inc (2018–2024)

Financial flexibility index of Kronos Bio Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Kronos Bio Inc across 7 annual periods. Explore KRON operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Kronos Bio Inc Financial Flexibility Index by Year (2018–2024)

Kronos Bio Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Kronos Bio Inc. For the full cash flow conversion analysis, see KRON operating cash flow.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -1.78x $-65.43 Million $-65.44 Million $36.78 Million ▼ -23.8%
2023 -1.44x $-77.90 Million $-78.58 Million $54.20 Million ▲ +19.8%
2022 -1.79x $-90.35 Million $-90.93 Million $50.44 Million ▲ +26.9%
2021 -2.45x $-113.66 Million $-117.92 Million $46.38 Million ▼ -301.6%
2020 -0.61x $-28.34 Million $-37.91 Million $46.45 Million ▼ -533.1%
2019 -0.10x $-12.13 Million $-15.08 Million $125.89 Million ▲ +64.2%
2018 -0.27x $-5.37 Million $-6.44 Million $19.91 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities